Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14900)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 14, 2025 (publication date) through Apr 16, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Rocha GR, Lemos FFB, Silva LGO, Luz MS, Correa Santos GL, Rocha Pinheiro SL, Calmon MS, de Melo FF. Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches. World J Gastroenterol 2025; 31(10): 102289 [PMID: 40093672 DOI: 10.3748/wjg.v31.i10.102289] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Rocha GR, Lemos FFB, Silva LGO, Luz MS, Correa Santos GL, Rocha Pinheiro SL, Calmon MS, de Melo FF. Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches. World J Gastroenterol 2025; 31(10): 102289 [PMID: 40093672 DOI: 10.3748/wjg.v31.i10.102289] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i10/102289.htm |
| Number | Citing Articles |
| 1 |
Oluwakemi Opeyemi Akinpelu, Humphrey Sam Samuel, David Akpanke Undie, Francis Arinze Ibekwe, Onimisi Princewill Onotu, Emmanuel Edet Etim. Current concepts of Helicobacter pylori infection. European Journal of Medical Research 2025; 31(1) doi: 10.1186/s40001-025-03725-7
|
| 2 |
Identification of Antimicrobial Peptide Variants From Lactobacillus spp. Against H. pylori-Mediated Gastric Cancer: An In-Silico Approach. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2026; 26(1): 60 doi: 10.7704/kjhugr.2025.0049
|
| 3 |
E. V. Luzina, L. B. Lazebnik, N. V. Lareva, A. A. Dutova, E. A. Tomina, L. V. Fedorova. Prevalence and genotypic resistance of Helicobacter pylori to clarithromycin in medical staff in the Transbaikal region. Experimental and Clinical Gastroenterology 2026; (7): 53 doi: 10.31146/1682-8658-ecg-239-7-53-59
|
| 4 |
Elif Aydin, Ayse Kocak Sezgin, Meliha Koldemir Gunduz, Birkan Açikgoz, Güllü Kaymak, Sercan Simsek. Natural supplements effectively suppress Helicobacter pylori colonization and improve gastric antioxidant and antiinflammatory responses in an indomethacin-induced ulcer model. Microbial Pathogenesis 2026; 213: 108320 doi: 10.1016/j.micpath.2026.108320
|
| 5 |
Tehsin Ullah Khan, Mohamed Sharaf, Sohaib Khan, Khurshid Ahmad, Chen-Guang Liu.
Advanced nano-delivery systems in
H. pylori
eradication: targeting, efficacy, and clinical translation
. Expert Opinion on Drug Delivery 2026; 23(1): 61 doi: 10.1080/17425247.2025.2569642
|
| 6 |
Prakash Goudanavar. An Innovative Approach for the Elimination of Helicobacter pylori: Floating Microballoons for the Prolonged Delivery of Antibiotics. Biomedical Materials & Devices 2026; doi: 10.1007/s44174-025-00632-7
|
| 7 |
S. Yu. Serebrova, A. B. Prokofiev, E. Yu. Esakova, I. A. Komissarenko, M. V. Zhuravleva. Acid intolerance of macrolides: clinical significance and ways of correction. Experimental and Clinical Gastroenterology 2026; (7): 88 doi: 10.31146/1682-8658-ecg-239-7-88-98
|
| 8 |
Surbhi Dumra, Abhishek Ray. Recent advances in Helicobacter pylori diagnosis, treatment, and management: a comprehensive review. Exploration of Digestive Diseases 2025; 4 doi: 10.37349/edd.2025.100598
|
| 9 |
Koji Otani, Wan Ying Lai, Jyh‐Ming Liou, Yasuhiro Fujiwara. Antibiotic Resistance in Helicobacter pylori in the Asia‐Pacific Region: A Call for Coordinated Regional Strategies. Journal of Gastroenterology and Hepatology 2026; 41(2): 387 doi: 10.1111/jgh.70227
|
| 10 |
Pesila Odera, Geoffrey Otieno, Joab Onyango, Bernhards Ogutu, James Owour, Florence Oloo, Martin Ongas, Hulda Swai, Jeremiah Gathirwa, Arnab Biswas. Nanoformulation and Preclinical Evaluation of Dihydroartemisinin–Lumefantrine and Primaquine as Combined Antimalarial Therapy. Journal of Nanotechnology 2025; 2025(1) doi: 10.1155/jnt/5162847
|
| 11 |
Vidya Suresh, Amritavarshini Sreekumar, Anil Kumar, Shine Sadasivan, Raja Biswas, Lalitha Biswas. Therapeutic advances and future directions in Helicobacter pylori eradication. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1652943
|
| 12 |
Dequan Shi, Yuhao Li, Rongshou Zheng, Shengfeng Wang, Ru Chen. Socioeconomic inequalities and dynamic changes in sex differences in lifetime risks of peptic ulcer disease. Biology of Sex Differences 2026; 17(1) doi: 10.1186/s13293-026-00832-w
|
| 13 |
Yanghe Liu, Shiyue Chen, Chunlei Zhang, Hui Xue, Muhammad Usman Abubakar, Sijie Yin, Xincheng Yang, Boyue Fan, Ping Tai, Mengqiu Xiong, Jingjing Li, Bangshun He. Asy-RPA/PCR combined with One-crRNA-CRISPR/Cas12a for simultaneous detection of multiple Clarithromycin resistance mutations in Helicobacter pylori. Nanomedicine: Nanotechnology, Biology and Medicine 2026; 74: 102942 doi: 10.1016/j.nano.2026.102942
|
| 14 |
Wen Gao, Jingwen Li, Guibin Yang, Shiyu Du, Tingsheng Ling, Xuezhi Zhang, Hui Ye, Yihong Xiong, Yuling Tian, Jianxiang Liu, Binbin Liu, Chi Wang, Hong Cheng. Vonoprazan-Tetracycline Dual Regimen as Rescue Therapy for Helicobacter pylori Infection: Randomized Controlled Trial. Gastroenterology 2026; doi: 10.1053/j.gastro.2026.01.008
|
| 15 |
Sourav Pal, Junaid Ahamed Laskar, Biprojit Bhowmick, Khokan Bera. Helicobacter pylori in peptic ulcer disease: pathogenesis, gastric microbiome, and innovative therapies. Bulletin of the National Research Centre 2025; 49(1) doi: 10.1186/s42269-025-01346-y
|
| 16 |
Ayman Elbehiry, Eman Marzouk, Adil Abalkhail. Unraveling Helicobacter pylori: Insights into Pathogenesis, Immune Evasion, and Progress Toward Effective Vaccination. Vaccines 2025; 13(7): 725 doi: 10.3390/vaccines13070725
|
| 17 |
Iyad A Issa, Pierre Zalloua, Taly Issa. Resistance reversal: Taiwan’s <i>Helicobacter pylori</i> trends defy global norms. World Journal of Gastroenterology 2025; 31(47): 114789 doi: 10.3748/wjg.v31.i47.114789
|
| 18 |
Dimple Guleria, Priyanka Sharma, Shikha Dhiman, Amit Kumar Sehgal. Antioxidant, antibacterial, and enzyme inhibitory properties of Dysphania ambrosioides (L.) Mosyakin & Clemants and its network pharmacology-based mechanisms against chronic superficial gastritis. Pharmacological Research - Natural Products 2026; 10: 100559 doi: 10.1016/j.prenap.2026.100559
|
| 19 |
Yurong Huang, Juan Zheng, Zhengyi Yang, Daili Li, Hua Wu, Wenzhong Chen, Wenjuan Wang, Min Gan, Changmei Shi, Dongmei Xie, Canyu Zhan, Gengqing Song, Jie Yang. Real-world effectiveness of vonoprazan-based regimen versus rabeprazole-based dual therapy for Helicobacter pylori eradication in a high-resistance, multi-ethnic region: a multicenter study in Guizhou, China. Frontiers in Medicine 2026; 13 doi: 10.3389/fmed.2026.1801129
|
| 20 |
Mohammad Javad Tahmasebi, Mahmoud Osanloo, Alireaza Tavassoli, Abbas Abdollahi, Elham Zarenezhad, Fatemeh Norouzi, Behnoosh Miladpour, Shilei Hao. Therapeutic Effect of Eugenol‐Loaded Chitosan Nanoparticles Against Helicobacter pylori Infection: A Histologic and Molecular Study. International Journal of Biomaterials 2026; 2026(1) doi: 10.1155/ijbm/6699913
|
| 21 |
Kareem Ibraheem, Osama Hroub, Abdalrahman N. Herbawi, Majed Dwaik. Helicobacter pylori - Diagnosis, Pathogenesis, and Treatment Strategies. 2025; doi: 10.5772/intechopen.1010640
|
| 22 |
Qiang Song, Huimin Wu, Zhengcai Ma, Ting Huang, Xinhu Zhu, Zhipeng Zhang, Guicheng Wu, Rakia Manzoor, Shiyu Liu, Ye Wang, Xuegang Li, Wenjin Zhang, Xiaoli Ye, Hang Ma.
The functional and catalytic landscape of urease reveals a conserved target against
Helicobacter pylori
. Gut Microbes 2026; 18(1) doi: 10.1080/19490976.2026.2653575
|
| 23 |
Zhuo-Qi Liu, Ben-Gang Zhou, Yuan-Yuan Chen, Jing-Wen Fang, Yue Yu, Min Zhang, Yan-Bing Ding. Association of visceral obesity with Helicobacter pylori seropositivity and mortality in US adults. BMC Infectious Diseases 2026; 26(1) doi: 10.1186/s12879-026-12915-5
|
| 24 |
Shafee Ur Rehman. A bioinformatics-based approach to develop genome-editing strategies against Helicobacter pylori infections. International Journal of Health Sciences 2026; 20: 53 doi: 10.25259/IJHS_192_2025
|
| 25 |
COMPARATIVE EFFICACY OF VONOPRAZAN AND PROTON PUMP INHIBITORS IN HELICOBACTER PYLORI ERADICATION BASED ON CLARITHROMYCIN SUSCEPTIBILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS. Asian Journal of Pharmaceutical and Clinical Research 2025; : 133 doi: 10.22159/ajpcr.2025v18i9.55714
|
| 26 |
Jun-Hyung Cho, So-Young Jin.
Diagnosis and treatment of
Helicobacter pylori
infection: past, present, and future
. Future Microbiology 2025; 20(13): 913 doi: 10.1080/17460913.2025.2568326
|
| 27 |
Shivani Kunkalienkar, Neha S. Gandhi, Ashutosh Gupta, Moumita Saha, Aravinda Pai, Shiran Shetty, Abhishek Gupta, Namdev Dhas, Raghu Chandrashekar Hariharapura, K. Nandakumar, Nagalakshmi Narasimhaswamy, Sudheer Moorkoth. Targeting Urease: A Promising Adjuvant Strategy for Effective Helicobacter pylori Eradication. ACS Omega 2025; 10(27): 28643 doi: 10.1021/acsomega.5c02725
|